![Amazon.com: Metagenics - OmegaGenics Neuro 1000, 750 mg DHA and 250 mg EPA, Concentrated, Purified Source of Omega-3 Fatty acids, 60 Count : Health & Household Amazon.com: Metagenics - OmegaGenics Neuro 1000, 750 mg DHA and 250 mg EPA, Concentrated, Purified Source of Omega-3 Fatty acids, 60 Count : Health & Household](https://m.media-amazon.com/images/I/814f+wgMmHL.jpg)
Amazon.com: Metagenics - OmegaGenics Neuro 1000, 750 mg DHA and 250 mg EPA, Concentrated, Purified Source of Omega-3 Fatty acids, 60 Count : Health & Household
![Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial - Journal of the American Academy of Child & Adolescent Psychiatry Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/asset/6fc0de69-d066-4196-af24-f20a9347b708/gr1.jpg)
Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial - Journal of the American Academy of Child & Adolescent Psychiatry
![Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis - ScienceDirect Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0890856711004849-gr1.jpg)
Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis - ScienceDirect
Does omega‑3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patient
![High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels | Translational Psychiatry High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels | Translational Psychiatry](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41398-019-0633-0/MediaObjects/41398_2019_633_Fig1_HTML.png)
High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels | Translational Psychiatry
![High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels | Translational Psychiatry High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41398-019-0633-0/MediaObjects/41398_2019_633_Fig1_HTML.png)